The U.S. Department of Defense aims to gird its bases in war zones and hot spots with biometric technology. That may not be enough.
|
After the hype, and then the lull, biotechs are making progress in pushing RNAi therapies into real-world treatments and real-deal revenues.
|
EShare happy with Acuity's chatty customer base
|
|
|